We are monitoring the impact of COVID-19 on North America Renal Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1218
Share on
Share on

North America Renal Disease Therapeutics Market Research Report – Segmented By Application, Treatment Devices & Country (the United States, Canada and Rest of North America) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1218
Pages: 145

North America Renal Disease Therapeutics Market Size (2021 to 2026)

The size of the North America Renal Disease Therapeutics Market is forecasted to be growing at a robust CAGR between 2021 to 2026. North America is projected to show the highest share in the market owing to the increasing incidence of renal failure and increasing awareness about renal diseases.

The market for renal diseases in North America is expected to grow significantly due to the proliferation of chronic and acute diseases and growing awareness among the people about the disease prevalence. On the other hand, the surge in the patient base of hypertension and lifestyle-associated diseases is the primary reason for increasing kidney-related conditions expected to increase the demand for treatment devices during the forecast period. Growing geriatric population base associated with kidney-related diseases and increasing renal disease are majorly propelling the market growth. Because of the increased prevalence of renal diseases, doctors are increasingly turning to advanced renal disease treatment devices, which allow for faster treatment and recovery. 

The expansion of this market is being fuelled by technological improvements such as point-of-care drug delivery systems and an increasing emphasis on maintaining one's personal quality of life. Moreover, the development of safe and effective innovative treatments for renal disease treatment supports the market's growth.

Furthermore, supportive government regulations, expanding research and development activities, and increased use of personalized medicine are projected to drive the renal disease treatment devices market growth throughout the forecast period. In addition, other market factors, such as improved healthcare infrastructure and the launch of innovative medicines in renal disease treatment devices, are projected to increase the market throughout the projection period, particularly in developed nations such as the United States and Canada. 

Adverse societal effects, such as disparities in renal transplant therapy, the expiration of patents on several branded medicines for late-stage CKD, and shifting reimbursement scenarios in some key countries, are limitations on the renal diseases market growth. 

This research report on the North American renal disease therapeutics market has been segmented and sub-segmented into the following categories:

By Treatment:

  • Dialysis Equipment
  • Renal Denervation Devices
  • Wearable Artificial Kidney Device
  • Distal Embolic Protection Devices

By Application Mode:

  • Kidney Stone Disease
  • End-Stage Kidney Disease
  • Kidney Failure
  • Chronic Kidney Disease
  • Hypertension
  • Diabetes
  • Anemia

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American renal diseases market is witnessing significant growth owing to the increasing number of individuals with insurance due to the Affordable Care Act and increasing healthcare expenditure. The largest market growth contributors, such as the United States and Canada, significantly contribute to the North American regional market growth. The U.S. dominated the renal disease market and is most likely to continue its domination in the coming years. The prevalence of chronic diseases is expected to drive renal disease treatment devices in the U.S. Also, favorable reimbursement policies, availability of advanced healthcare infrastructure, and government funding for R&D providing lucrative opportunities for market growth. As a result, the increasing adoption of technologically advanced devices, especially in the hospitals, fueling the growth of the U.S. market during the forecast period. The ESRD reimbursement system, which integrates payments for dialysis, medicines, and lab tests into one single payment to limit the cost of dialysis treatments, was launched in the United States on January 1, 2011. It is projected to drive the market at a rapid pace. 

The Canadian market is anticipated to witness a promising share in the market due to the growing geriatric population base, increasing healthcare spending, and evolving healthcare sector.


Some of the key players in this market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, Davita Healthcare Partners.


                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Kidney Stone Disease         

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure        

                                5.1.5 Chronic Kidney Disease     

                                5.1.6 Hypertension        

                                5.1.7 Diabetes  

                                5.1.8 Anaemia  

                                5.1.4 Y-o-Y Growth Analysis, By Application         

                                5.1.5 Market Attractiveness Analysis, By Application        

                                5.1.6 Market Share Analysis, By Application         

                5.2 Treatment devices                  

                                5.2.1 Introduction           

                                5.2.2 Dialysis Equipment              

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device   

                                5.2.5 distal embolic protection devices  

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices           

                                5.2.7 Market Attractiveness Analysis, By Treatment devices         

                                5.2.8 Market Share Analysis, By Treatment devices          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Application

                                       By Treatment Devices

                                6.1.4 Market Attractiveness Analysis      

                                       By Geographical Area

                                       By Application

                                       By Treatment devices

                                6.1.5 Market Share Analysis        

                                       By Geographical Area

                                       By Application

                                       By Treatmentr Devices

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Amgen Inc.                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co., Inc.                     

                8.3 Bristol-Myers Squibb Company                          

                8.4 Hoffmann-La Roche Inc                         

                8.5 Shire Inc.                     

                8.6 Fresenius Medical Care                         

                8.7 Baxter International               

                8.8 Davita Healthcare Partners                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Diabetes Care Devices Market, By Application, From 2021 to 2026 (USD Million)
  2. North America Kidney Stone Disease Market, By Region, From 2021 to 2026 (USD Million)
  3. North America End-Stage Kidney Disease Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Kidney Failure Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Chronic Kidney Disease Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Hypertension Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Anaemia Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Diabetes Care Devices Market, By Treatment Devices, From 2021 to 2026 (USD Million)
  10. North America Dialysis Equipment Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Renal Denervation Devices Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Wearable Artificial Kidney Device Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Distal Embolic Protection Devices Market, By Region, From 2021 to 2026 (USD Million)
  15. United States Diabetes Care Devices Market, By Application, From 2021 to 2026 (USD Million)
  16. United States Diabetes Care Devices Market, By Treatment Devices, From 2021 to 2026 (USD Million)
  17. Canada Diabetes Care Devices Market, By Application, From 2021 to 2026 (USD Million)
  18. Canada Diabetes Care Devices Market, By Treatment Devices, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample